P

    Pluri Inc. (PLUR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.47
    -0.06 (-3.92%)

    Market Cap: $16.51M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(22/32)
    Avg Surprise
    +9.41%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$-0.66
    Range$-0.66 - $-0.66
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.66
    Revenue Consensus
    $655000
    Range$655000 - $655000
    1 analysts
    Period ending Jun 30, 2026
    EPS Consensus$-0.65
    Range$-0.65 - $-0.65
    1 analysts
    Revenue Consensus
    $-1931000
    Range$-1931000 - $-1931000
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-$-0.65---
    Mar 26EST
    		-$-0.66---
    Sep 25
    Reported Nov 12
    		$-0.65$-0.74+12.16%Beat+39.7%
    Jun 25
    Reported Sep 17
    		$-1.00$-0.73-36.99%Miss+5.6%
    Mar 25
    Reported May 13
    		$-0.94N/AN/ABeat+7.6%
    Dec 24
    Reported Feb 11
    		$-0.53N/AN/ABeat-350.7%
    Sep 24
    Reported Nov 12
    		$-1.08$0.00N/ABeat-467.1%
    Jun 24
    Reported Sep 18
    		$-1.06$0.00N/ABeat-562.1%
    Mar 24
    Reported May 9
    		$-1.01$0.00N/ABeat-433.6%
    Dec 23
    Reported Feb 12
    		$-0.12N/A+63.09%Beat+93.8%
    Sep 23
    Reported Nov 13
    		$-0.19$-0.32+40.63%Beat+87.5%
    Jun 23
    Reported Sep 12
    		$-0.16$-0.31+48.39%Beat+42.9%
    Mar 23
    Reported May 9
    		$-0.19$-0.30+36.67%Beat+92.3%
    Dec 22
    Reported Feb 13
    		$-1.92$-2.56+25.00%Beat+29.4%
    Sep 22
    Reported Nov 10
    		$-1.52$-2.56+40.63%Beat+47.2%
    Jun 22
    Reported Sep 21
    		$-0.28$-0.35+20.00%Beat+39.1%
    Mar 22
    Reported May 9
    		$-2.48$-3.20+22.50%Beat+35.4%
    Dec 21
    Reported Feb 7
    		$-2.72$-3.04+10.53%Beat+30.6%
    Sep 21
    Reported Nov 8
    		$-2.88$-3.28+12.20%Beat-9.1%
    Jun 21
    Reported Sep 13
    		$-0.46$-0.40-15.00%Miss-43.8%
    Mar 21
    Reported May 6
    		$-3.84$-3.07-25.08%Miss-14.3%
    Dec 20
    Reported Feb 8
    		$-3.92$-2.64-48.48%Miss-22.5%
    Sep 20
    Reported Nov 5
    		$-2.64$-1.80-46.67%Miss+28.3%
    Jun 20
    Reported Sep 10
    		$-0.32$-0.36+11.11%Beat+49.2%
    Mar 20
    Reported May 11
    		$-3.36$-3.32-1.20%Miss+53.3%
    Dec 19
    Reported Feb 6
    		$-3.20$-4.28+25.23%Beat+42.9%
    Sep 19
    Reported Nov 7
    		$-3.68$-5.20+29.23%Beat+42.5%
    Jun 19
    Reported Sep 12
    		$-0.63$-0.63+0.00%Beat+30.0%
    Mar 19
    Reported May 6
    		$-7.20$-6.00-20.00%Miss-800.0%
    Dec 18
    Reported Feb 6
    		$-5.60$-6.93+19.19%Beat+12.5%
    Sep 18
    Reported Nov 7
    		$-6.40$-7.20+11.11%Beat+0.0%
    Jun 18
    Reported Sep 12
    		$-0.90$-0.70-28.57%Miss-28.6%
    Mar 18
    Reported May 9
    		$-0.80N/A+88.24%Beat+88.9%
    Dec 17
    Reported Feb 6
    		$-6.40$-6.40+0.00%Beat+0.0%
    Sep 17
    Reported Nov 7
    		$-6.40$-6.67+4.05%Beat+0.0%
    Jun 17
    Reported Sep 7
    		$-0.70$-0.90+22.22%Beat-
    Mar 17
    Reported May 8
    		$-7.20$-6.40-12.50%Miss-
    Dec 16
    Reported Feb 8
    		$-6.40$-6.00-6.67%Miss-
    Sep 16
    Reported Nov 7
    		$-6.40$-6.40+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.47EV/EBITDA-1.28x
    Price/FCF-0.68xFCF Yield-146.74%
    Profitability
    Profit Margin0.00%Operating Margin-3914.00%
    ROE-1022.00%ROIC-290.87%
    Financial Health
    Debt/Equity-1.47xInterest CoverageN/A
    Current Ratio0.33xQuick Ratio0.33x
    Trading Statistics
    Beta0.68Avg Volume28.34K
    52-Week High$5.2952-Week Low$1.43

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.61
    SMA 20$1.66
    SMA 50$1.78
    SMA 200$2.87
    EMA 10$1.58
    EMA 20$1.63
    EMA 50$1.84
    EMA 200$2.78

    MACD

    Line: -0.08Signal: -0.07Hist: -0.01

    ADX

    ADX: 16.4+DI: 16.2-DI: 25.1

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$1.81

    Bollinger Bands

    Upper Band$1.89
    Lower Band$1.43
    %B Position2776%(Upper)
    Band Width0.10

    RSI (14-Day)

    Neutral
    38.6

    Momentum Oscillators

    Stoch %K17.2
    Stoch %D16.6
    Williams %R-89.2
    ROC (10d)-8.1%
    Momentum-0.13
    CCI (20d)-133.3
    MFI (14d)40.1

    Volatility Measures

    ATR (14d)$0.14(9.4%)
    StdDev (20d)0.11
    Hist Vol88.1%(High)

    Volume Flow

    VWAP$1.49
    OBV719.8K
    AD Line-1.4M
    CMF (20d)-0.282

    Volume Metrics

    Avg Vol (20d)29.6K
    Vol Ratio1.7x(High)
    VWMA (20d)$1.59

    Pivot Points

    R3$1.79
    R2$1.71
    R1$1.62
    Pivot Point$1.54
    S1$1.45
    S2$1.37
    S3$1.28

    Advanced Oscillators

    TSI-16.06
    Ultimate Osc32.5
    KST-82.85

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$167,000$198,000$316,000$398,000$427,000$185,000$326,000$96,000$71,000$105,000$54,000$-122,000
    Cost of Revenue$111,000$112,000$201,000$191,000$291,000$74,000$126,000$4,000$0$0$0$9,000
    Gross Profit$56,000$86,000$115,000$207,000$136,000$111,000$200,000$92,000$71,000$105,000$54,000$-131,000
    Operating Expenses$9.97M$6.74M$6.46M$1.14M$9.49M$3.01M$5.40M$716,000$5.61M$5.32M$4.94M$4.70M
    R&D$7.94M$3.83M$3.93M$-2,411,000$6.28M$2.92M$2.89M$-3,305,000$3.09M$2.96M$2.99M$3.29M
    SG&A$2.63M$2.77M$2.53M$2.83M$2.49M$2.14M$2.51M$2.73M$2.51M$2.35M$2.44M$3.12M
    Operating Income$-6,536,000$-6,506,000$-6,350,000$-6,621,000$-5,400,000$-4,957,000$-5,198,000$-6,034,000$-5,534,000$-5,213,000$-5,377,000$-6,544,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$237,000$231,000$229,000$0$212,000$211,000$217,000$0$218,000$216,000$0$0
    Income Before Tax$-6,180,000$-6,880,000$-6,140,000$-2,498,000$-6,335,000$-3,110,000$-6,036,000$261,000$-5,390,000$-4,994,000$-4,884,000$-5,051,000
    Income Tax Expense$-8,000$-8,000$-8,000$0$0$0$0$0$0$0$0$0
    Net Income$-11,720,000$-6,872,000$-6,132,000$-21,249,000$-12,482,000$-3,110,000$-6,036,000$-16,552,000$-5,390,000$-4,994,000$-5,098,000$-6,606,000
    EBITDA$-6,052,000$-6,377,000$-6,220,000$-6,510,000$-6,263,000$-4,889,000$-5,133,000$-5,973,000$-5,329,000$-4,930,000$-5,310,000$-6,467,000
    EBIT$-6,180,000$-6,506,000$-6,350,000$-6,621,000$-6,335,000$-4,957,000$-5,198,000$-6,034,000$-5,390,000$-4,994,000$-5,377,000$-6,544,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PLUR

    News

    Pluri (PLUR) director's 31,569-share grant vests over 3 years

    Pluri Inc. (PLUR) director Doron Shorrer was granted 31,569 Restricted Stock Units (RSUs) on August 20, 2026, which will vest over a three-year period. Following this grant, Shorrer directly holds 38,228 common shares and indirectly holds 6,969 common shares through Shorrer International Ltd. The RSUs vest with 50% in the first year, 25% in the second, and 25% in the third, all on a quarterly basis.

    Stock Titan•8/25/26•
    Neutral

    Pluri Inc. (PLUR) insider logs stock trades in new SEC filing

    Pluri Inc. (PLUR) director and 10% owner Manieu Alexandre Weinstein has filed a Form 4 with the SEC, indicating the grant of 180,000 common shares underlying restricted stock units (RSUs) on August 20, 2026. These RSUs will vest over three years. Following this transaction, Weinstein directly holds 190,769 common shares and indirectly holds significant additional shares through Chutzpah Holdings LP, Chutzpah Holdings Ltd., and Plantae Biosciences Ltd.

    Stock Titan•8/24/26•
    Neutral

    Pluri Subsidiary to Acquire Fishway BV, Diluting Pluri Stake to 58%

    Pluri Inc.'s majority-owned subsidiary, Ever After Foods Ltd. (EAF), is set to acquire Fishway BV in an all-stock deal, aiming to strengthen EAF's European strategy in cultivated seafood. While this acquisition will bolster EAF's research capabilities and is supported by a $2.0 million SAFE investment, Pluri's ownership stake in EAF will be diluted from 69% to approximately 58%. This transaction is at the subsidiary level and does not involve direct cash infusion into Pluri Inc.

    Minichart•8/17/26•
    Neutral

    Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment

    Pluri's majority-owned food-tech company, Ever After Foods (EAF), has acquired Fishway BV, a Belgium-based biotechnology company specializing in aquatic cell biology and animal-component-free media development. This acquisition enhances EAF's cultivated-protein platform and expands its European scientific presence. Concurrently, EAF secured an additional $2 million strategic investment to support its ongoing development and commercialization activities.

    GlobeNewswire•8/17/26•
    Bullish

    Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment

    Pluri's majority-owned food-tech company, Ever After Foods (EAF), has acquired Fishway BV, a Belgian biotechnology company specializing in aquatic cell biology and animal-component-free media. This acquisition enhances EAF's cultivated-protein platform, expands its European presence, and strengthens its capabilities for diverse applications. Concurrently, EAF secured an additional $2 million strategic investment to support its ongoing development and commercialization efforts.

    GlobeNewswire•8/17/26•
    Bullish

    Frequently Asked Questions About PLUR

    Does PLUR pay dividends?
    Pluri Inc. (PLUR) does not currently pay a regular dividend.
    What is PLUR's market cap?
    Pluri Inc. (PLUR) has a market capitalization of $16.51M with a current stock price of $1.47.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In